7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one
Spécifications
199327-61-2Numéro CAS
429-400-7Numéro CE
7-methoxy-6-(3-morpholin-4-ylpropoxy)-3H-quinazolin-4-oneNom IUPAC
C16H21N3O4Formule chimique
319.36 g/molMasse molaire
7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; EC 429-400-7; 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one; RefChem:546718; 429-400-7; 199327-61-2; 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one; 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one; Gefitinib Impurity 5; MFCD12760130; Gefitinib EP Impurity A; 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone; 4(3H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-; R9YH59H93M; 7-methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one; 7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(1h)-one; 7-Methoxy-6-(3-morpholinopropoxy)-quinazolin-4(3H)-one; 7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(3H)-one; 7-Methoxy-6-(3-(4-morpholinyl)propoxy)-4(3H)-quinazolinone; Gefitinib Impurity C; 4(1H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-; UNII-R9YH59H93M; SCHEMBL829762; 7-methoxy-6-(3-morpholinopropoxy)-1H-quinazolin-4-one; SCHEMBL25281864; SCHEMBL28431957; SCHEMBL29478512; SCHEMBL29478513; DTXSID90439401; Gefitinib related compound A [USP]; 7-methoxy-6-[3-(morpholin-4-yl)propoxy]-3,4-dihydroquinazolin-4-one; AKOS015917892; AKOS025401601; DS-1851; FD16024; AC-22622; SY039369; DB-066001; HY-133779; CS-0131955; NS00077739; F793847; 7-methoxy-6-(3-morpholin-4-ylpropoxy)-3H-quinazolin-4-one; 7-methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin4-one; 7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(1H)-one; 7-methoxy-6-[3-(morpholin-4-yl)propoxy]-1,4-dihydroquinazolin-4-oneSynonymes